Optiver Holding
AMRX icon

Optiver Holding’s Amneal Pharmaceuticals AMRX Stock Holding History

Optiver Holding’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Buy
+1,277
New +$17.5K ﹤0.01% 1482
2026
Q1 		– Sell
-268
Closed -$3.38K – 2315
2025
Q4 		$3.38K Sell
268
-584
-69% -$6.68K ﹤0.01% 1672
2025
Q3 		$8.53K Sell
852
-210
-20% -$1.89K ﹤0.01% 1391
2025
Q2 		$8.59K Buy
1,062
+730
+220% +$5.5K ﹤0.01% 1046
2025
Q1 		$2.78K Buy
+332
New +$2.77K ﹤0.01% 1198
2024
Q4 		– Sell
-1,245
Closed -$10.4K – 1037
2024
Q3 		$10.4K Sell
1,245
-578
-32% -$4.52K ﹤0.01% 734
2024
Q2 		$11.6K Buy
+1,823
New +$11.6K ﹤0.01% 697

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Optiver Holding's AMRX Position: Q2 2026 in Review

Optiver Holding opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 1,277 shares worth $22.1K. The stake represents ﹤0.01% of the portfolio and ranks #1482 among its holdings. This is a return to the name: Optiver Holding previously reported a position in AMRX as recently as Q4 2025.

Optiver Holding first reported a position in AMRX in Q2 2024 and has held it in 7 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Optiver Holding held 1,277 shares of Amneal Pharmaceuticals worth $22.1K as of Q2 2026.
  • Amneal Pharmaceuticals was a new Optiver Holding position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1482 holding.
  • Optiver Holding first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.